{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:37:01Z","timestamp":1777333021163,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02066-1","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:45:52Z","timestamp":1773873952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ascitic fluid cell block with immunocytochemistry for the diagnosis of advanced tubo-ovarian cancer: a retrospective study"],"prefix":"10.1186","volume":"19","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"2","key":"2066_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ygyno.2016.09.002","volume":"143","author":"A Melamed","year":"2016","unstructured":"Melamed A, Hinchcliff EM, Clemmer JT, Bregar AJ, Uppal S, Bostock I, et al. Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States. Gynecol Oncol. 2016;143(2):236\u201340.","journal-title":"Gynecol Oncol"},{"issue":"32","key":"2066_CR2","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1200\/JCO.2016.68.1239","volume":"34","author":"LA Meyer","year":"2016","unstructured":"Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, et al. Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2016;34(32):3854\u201363.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2066_CR3","first-page":"385","volume":"56","author":"D Wang","year":"2021","unstructured":"Wang D, Zhang G, Peng C, et al. Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced tubo-ovarian cancer [J]. Chin J Obstet Gynecol. 2021;56(6):385\u201392.","journal-title":"Chin J Obstet Gynecol"},{"issue":"3","key":"2066_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jum.15746","volume":"41","author":"R Penna","year":"2022","unstructured":"Penna R, Poder L, Jha P, Seigel EL, Morgan TA. Transvaginal Ultrasound-Guided Fine-Needle Aspiration Biopsy of Pelvic Lesions. J Ultrasound Med. 2022;41(3):653\u201361.","journal-title":"J Ultrasound Med"},{"issue":"4","key":"2066_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2214\/AJR.15.15702","volume":"206","author":"JJ Park","year":"2016","unstructured":"Park JJ, Kim CK, Park BK. Ultrasound-Guided Transvaginal Core Biopsy of Pelvic Masses: Feasibility, Safety, and Short-Term Follow-Up. AJR Am J Roentgenol. 2016;206(4):877\u201382.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"2066_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","volume":"13","author":"A Fagotti","year":"2006","unstructured":"Fagotti A, Ferrandina G, Fanfani F, Ercoli A, Lorusso D, Rossi M, et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol. 2006;13(8):1156\u201361.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"2066_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/cyt.12514","volume":"29","author":"X Zhang","year":"2018","unstructured":"Zhang X, Chen L, Liu Y, Xu Y, Zhang X, Shi Y, et al. Improving the cytological diagnosis of high-grade serous carcinoma in ascites with a panel of complementary biomarkers in cell blocks. Cytopathology. 2018;29(3):247\u201353.","journal-title":"Cytopathology"},{"issue":"2","key":"2066_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4314\/ejhs.v24i2.4","volume":"24","author":"VM Bhanvadia","year":"2014","unstructured":"Bhanvadia VM, Santwani PM, Vachhani JH. Analysis of diagnostic value of cytological smear method versus cell block method in body fluid cytology: study of 150 cases. Ethiop J Health Sci. 2014;24(2):125\u201331.","journal-title":"Ethiop J Health Sci"},{"issue":"2","key":"2066_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ygyno.2020.02.004","volume":"157","author":"T Uehara","year":"2020","unstructured":"Uehara T, Yoshida H, Fukuhara M, Yoshida M, Motoi N, Sugawara S, et al. Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites. Gynecol Oncol. 2020;157(2):398\u2013404.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"2066_CR10","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.5858\/arpa.2016-0125-RA","volume":"140","author":"A Saqi","year":"2016","unstructured":"Saqi A. The State of Cell Blocks and Ancillary Testing: Past, Present, and Future. Arch Pathol Lab Med. 2016;140(12):1318\u201322.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2066_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000495571","volume":"63","author":"Z Amiri","year":"2019","unstructured":"Amiri Z, Momtahan M, Mokhtari M. Comparison of Conventional Cytology, Liquid-Based Cytology, and Cell Block in the Evaluation of Peritoneal Fluid in Gynecology Malignancies. Acta Cytol. 2019;63(1):63\u201372.","journal-title":"Acta Cytol"},{"issue":"3","key":"2066_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/(SICI)1097-0339(199609)15:3<191::AID-DC3>3.0.CO;2-K","volume":"15","author":"ML Calabretto","year":"1996","unstructured":"Calabretto ML, Giol L, Sulfaro S. Diagnostic utility of cell-block from bronchial washing in pulmonary neoplasms. Diagn Cytopathol. 1996;15(3):191\u20132.","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"2066_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/0970-9371.55223","volume":"26","author":"M Thapar","year":"2009","unstructured":"Thapar M, Mishra RK, Sharma A, Goyal V, Goyal V. Critical analysis of cell block versus smear examination in effusions. J Cytol. 2009;26(2):60\u20134.","journal-title":"J Cytol"},{"issue":"3","key":"2066_CR14","first-page":"236","volume":"64","author":"R \u017divadinovi\u0107","year":"2015","unstructured":"\u017divadinovi\u0107 R, Petri\u0107 A, Krtini\u0107 D, Stevanovi\u0107 Milosevi\u0107 J. Pop Trajkovi\u0107 Dini\u0107 S. Ascites in Ovarian Carcinoma - Reliability and Limitations of Cytological Analysis. West Indian Med J. 2015;64(3):236\u201340.","journal-title":"West Indian Med J"},{"issue":"5","key":"2066_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.5858\/133.5.739","volume":"133","author":"O Lin","year":"2009","unstructured":"Lin O. Challenges in the interpretation of peritoneal cytologic specimens. Arch Pathol Lab Med. 2009;133(5):739\u201342.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2066_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/COC.0000000000000119","volume":"40","author":"VA Allen","year":"2017","unstructured":"Allen VA, Takashima Y, Nayak S, Manahan KJ, Geisler JP. Assessment of False-negative Ascites Cytology in Epithelial Ovarian Carcinoma: A Study of 313 Patients. Am J Clin Oncol. 2017;40(2):175\u20137.","journal-title":"Am J Clin Oncol"},{"key":"2066_CR17","doi-asserted-by":"crossref","unstructured":"Tauste Rubio C. Little clinical relevance of Ca125, Cea and Ca125\/Cea ratio for the differential diagnosis of ovarian and non- ovarian carcinomatosis. Women Health Care and Issues. 2021;4(5):01\u20137.","DOI":"10.31579\/2642-9756\/064"},{"issue":"11","key":"2066_CR18","first-page":"A4331","volume":"58","author":"SS S\u00f8rensen","year":"2011","unstructured":"S\u00f8rensen SS, Mosgaard BJ. Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis. Dan Med Bull. 2011;58(11):A4331.","journal-title":"Dan Med Bull"},{"issue":"2","key":"2066_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jso.2930440207","volume":"44","author":"PK Buamah","year":"1990","unstructured":"Buamah PK, Rake MO, Drake SR, Skillen AW. Serum CA 12\u2009\u2013\u20095 concentrations and CA 12\u2009\u2013\u20095\/CEA ratios in patients with epithelial ovarian cancer. J Surg Oncol. 1990;44(2):97\u20139.","journal-title":"J Surg Oncol"},{"issue":"1","key":"2066_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000071198","volume":"65","author":"A Sevinc","year":"2003","unstructured":"Sevinc A, Camci C, Turk HM, Buyukberber S. How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma. Oncology. 2003;65(1):1\u20136.","journal-title":"Oncology"},{"issue":"47","key":"2066_CR21","doi-asserted-by":"publisher","first-page":"e5177","DOI":"10.1097\/MD.0000000000005177","volume":"95","author":"CJ Huang","year":"2016","unstructured":"Huang CJ, Jiang JK, Chang SC, Lin JK, Yang SH. Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women. Med (Baltim). 2016;95(47):e5177.","journal-title":"Med (Baltim)"},{"issue":"28","key":"2066_CR22","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","volume":"34","author":"AA Wright","year":"2016","unstructured":"Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, et al. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34(28):3460\u201373.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2066_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.022","volume":"143","author":"AA Wright","year":"2016","unstructured":"Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, et al. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecol Oncol. 2016;143(1):3\u201315.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2066_CR24","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00404-020-05553-y","volume":"301","author":"J Krugmann","year":"2020","unstructured":"Krugmann J, Schwarz CL, Melcher B, Sterlacci W, Vieth M, R\u00f6sch S, et al. Diagnostic impact of ascites cytology in 941 patients: malignancy rates and time of detection in ovarian cancer relative to other tumor types. Arch Gynecol Obstet. 2020;301(6):1521\u201332.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"2066_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s004040000155","volume":"265","author":"DM Andresen","year":"2001","unstructured":"Andresen DM, Pedersen FH, Rasmussen KL. Adenocarcinoma of the small intestine mistaken as a primary ovarian cancer. Arch Gynecol Obstet. 2001;265(4):214\u20135.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"2066_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ygyno.2020.03.024","volume":"157","author":"DM Narasimhulu","year":"2020","unstructured":"Narasimhulu DM, Kumar A, Weaver AL, Langstraat CL, Cliby WA. Less guessing, more evidence in identifying patients least fit for cytoreductive surgery in advanced ovarian cancer: A triage algorithm to individualize surgical management. Gynecol Oncol. 2020;157(3):572\u20137.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"2066_CR27","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/GME.0000000000001534","volume":"27","author":"S Baransi","year":"2020","unstructured":"Baransi S, Michaan N, Gortzak-Uzan L, Aizic A, Laskov I, Gamzu R, et al. The accuracy of ascites cytology in diagnosis of advanced ovarian cancer in postmenopausal women prior to neoadjuvant chemotherapy. Menopause. 2020;27(7):771\u20135.","journal-title":"Menopause"},{"issue":"1","key":"2066_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/ajcp\/aqaa028","volume":"154","author":"A Bansal","year":"2020","unstructured":"Bansal A, Srinivasan R, Rohilla M, Sundaram A, Rai B, Rajwanshi A, et al. Morphologic and Immunocytochemical Features of High-Grade Serous Carcinoma of Ovary in Ascitic Fluid Effusion and Fine-Needle Aspiration Cytology. Am J Clin Pathol. 2020;154(1):103\u201314.","journal-title":"Am J Clin Pathol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02066-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:57:08Z","timestamp":1777330628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02066-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2066"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02066-1","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the research protocol by an Institutional Reviewer Board: This study was approved by the Institutional Ethics Committee of the Sichuan Cancer Hospital (Ethics approval number: KY-2025-246-01). The study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}